EXAS

Exact Sciences Corporation

Healthcare›Medical - Diagnostics & Research|NASDAQ Capital Market|US

Price

$104.91

Market Cap

$20.03B

Beta

1.44

P/E

0.0

Div Yield

—

Sector Median P/E

21.4

Key Metrics

Revenue Growth (YoY)+17.69%

EPS Growth (YoY)+80.30%

Revenue CAGR 3Y+15.92%

P/E Ratio0.0

PEG Ratio—

FCF Yield+1.78%

Debt / Equity1.05

Interest Coverage-5.5x

No credit card required

Already have an account? Sign in to view the full analysis for EXAS.